Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
Cardiome Pharma Corp. (NASDAQ: CRME) shares surged 24.88 percent to close at $5.12 a share Monday. The stock traded between $4.05 and $5.35 on volume of 1.25 million shares traded. The company announced publication of positive data from an observational, retrospective study performed at the Skåne University Hospital in Malmö, Sweden. Shares of Cardiome Pharma have gained approximately 155.0 percent year-to-date.
Get more information on Cardiome Pharma and free access to the in-depth equity report at:
GW Pharmaceuticals PLC (NASDAQ: GWPH) shares surged 28.99 percent to close at $31.86 a share Monday. The stock traded between $27.50 and $35.00 on volume of 1.73 million shares traded. Lazard Capital analyst Joshua Schimmer has raised his price target on the company to $65.00 from $22.00.
Get more information on GW Pharmaceuticals and free access to the in-depth equity report at:
InvenSense Inc. (NYSE: INVN) shares gained 5.80 percent to close at $19.71 a share Monday. The stock traded between $18.44 and $19.90 on volume of 4.74 million shares traded. Craig-Hallum believes that company has three design wins (Google's Nexus 5, Amazon Kindle Fire HD and Samsung Galaxy Gear). Shares of InvenSense have gained approximately 77.0 percent year-to-date.
Get more information on InvenSense and free access to the in-depth equity report at:
Outerwall Inc. (NASDAQ: OUTR) shares gained 3.96 percent to close at $59.36 a share Monday. The stock traded between $58.25 and $64.30 on volume of 6.26 million shares traded. Activist investment fund Jana Partners LLC has recently disclosed a 14 percent stake in the company. Shares of Outerwall have gained approximately 14.0 percent year-to-date.
Get more information on Outerwall free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities
Leave a comment...